// App-Quantinova.ai

: Drug Monitoring of Asparaginase Activity to Detect Silent Inactivation in Pediatric Acute Lymphoblastic Leukemia Patients Receiving Peg-Asparaginase

Researchers

Presenter

  • Van Thu Huynh

Principal Investigators

  • Alexa Love

  • Mary English

  • Carol Hwang Lin

Medical Centers

  • CHOC Childrens Hospital, Orange, CA

  • UC Irvine School of Medicine, Orange, CA

  • UC Irvine School of Medicine, Costa Mesa, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • PEG-asparaginase

  • Erwinase

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A